AMENDED AND RESTATED COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • October 3rd, 2008 • Repros Therapeutics Inc. • Biological products, (no disgnostic substances) • Texas
This AMENDED AND RESTATED COMMON STOCK PURCHASE AGREEMENT (the “Agreement”), is made as of September 29, 2008 by and between Repros Therapeutics Inc., a Delaware corporation, with its principal executive offices located at 2408 Timberloch Place, Suite B-7, The Woodlands, Texas 77380 (the “Company”), and Cyan Opportunities Fund, Ltd. (the “Investor”).
SECOND AMENDMENT TO STANDSTILL AGREEMENTStandstill Agreement • October 3rd, 2008 • Repros Therapeutics Inc. • Biological products, (no disgnostic substances) • Delaware
This SECOND AMENDMENT TO STANDSTILL AGREEMENT (the “Amendment”), dated as of October 2, 2008, is by and between REPROS THERAPEUTICS INC., a Delaware corporation (the “Issuer”), and EFFICACY CAPITAL, LTD (“Efficacy”).
